SPH Notice - Cooper Investors Pty Limited

100080615/3821103.1
Disclosure of movement of 1% or more in substantial holding
or change in nature of relevant interest, or both
Sections 277 and 278, Financial Markets Conduct Act 2013
Note: This form must be completed in accordance with the instructions at the end of the
form.
To NZX Limited
and
To Ryman Healthcare Limited
Relevant event being disclosed: Movement of 1% or more in substantial holding
Date of relevant event: 3 December 2024
Date this disclosure made: 4 December 2024
Date last disclosure made: 1 November 2024
Substantial product holder(s) giving disclosure
Full name(s): Cooper Investors Pty Limited (ABN 26 100 409 890) of level 12, 8 Exhibition
St, Melbourne, 3000, Victoria, Australia,
Contact details:
Jacqueline Verhaeg, Head of Compliance, (+61) 03 9660 2632 or
jverhaeg@cooperinvestors.com
Summary of substantial holding
Class of quoted voting products: Ordinary share
Summary for Cooper Investors Pty Limited
For this disclosure,—
(a) total number held in class: 44,787,762
(b) total in class: 687,641,738
(c) total percentage held in class: 6.5132%
For last disclosure,—
(a) total number held in class: 34,896,071
(b) total in class: 687,641,738
(c) total percentage held in class: 5.0747%
Details of transactions and events giving rise to relevant event

100080615/3821103.1
Details of the transactions or other events requiring disclosure: See Annexure A
Details after relevant event

Details for Cooper Investors Pty Ltd
Nature of relevant interest(s): registered holder
For that relevant interest,—
(a) number held in class: 44,787,762
(b) percentage held in class: [6.5132%]
(c) current registered holder(s): that no change since last disclosure
(d) registered holder(s) once transfers are registered: N/A
For a derivative relevant interest, also—
(a) type of derivative: N/A
(b) details of derivative: N/A
(c) parties to the derivative: N/A
(d) if the substantial product holder is not a party to the derivative, the nature of the
relevant interest in the derivative: N/A
Additional information
Address(es) of substantial product holder(s): N/A
Contact details: N/A
*Nature of connection between substantial product holders: N/A
*Omit if disclosure is made for only 1 substantial product holder.
Name of any other person believed to have given, or believed to be required to give, a
disclosure under the Financial Markets Conduct Act 2013 in relation to the financial
products to which this disclosure relates: N/A
*Disclosure has effect for purposes of directors’ and senior managers’ disclosure
N/A
*Omit if inapplicable (see section 302 of the Financial Markets Conduct Act 2013).
Certification
I, Jacqueline Verhaeg, certify that, to the best of my knowledge and belief, the
information contained in this disclosure is correct and that I am duly authorised to make
this disclosure by all persons for whom it is made.

100080615/3821103.1

Instructions
General directions on how to use this form
To use this form,—
• replace the text in [square brackets] with the relevant information or with “not
applicable”; and
• type the information required (it must not be handwritten); and
• remove italicised instructions; and
• attach the relevant agreement documents required by regulation 139 (if any).
You need not set out the disclosure in the same format as this form, but the format you
use must—
• use a font and font size that are easily readable; and
• include the same headings and words as this form (other than the italicised
instructions); and
• present the information in the same order as in this form; and
• not be misleading in any way.
If you have a substantial holding in more than 1 class of quoted voting products of a listed
issuer, you must make a separate disclosure for each substantial holding.
If you have a substantial holding in 1 class of quoted voting products of a listed issuer and
other relevant interests in less than 5% of another class, you do not need to disclose the
non-substantial holding.
Disclosure to the licensed market operator using this form must be sent (if reasonably
possible) by email in the electronic format required by the operator for dissemination, or
otherwise by email in another electronic format, by another electronic method consented
to by the operator, or (if none of these is reasonably possible) by delivery.
Disclosure to the listed issuer using this form must be sent by email or another electronic
method consented to by the issuer or by delivery.
Specific instructions on disclosure required by form
The relevant event being disclosed is a movement of 1% or more in the substantial
holding or a change in the nature of any relevant interest in the substantial holding, or
both. Both types of relevant events may be disclosed in 1 disclosure only if they relate to
the same substantial holding.

100080615/3821103.1
The date of relevant event is the date of the relevant event for disclosure in this form,
and it may be relevant to subsequent disclosures for this substantial holding.
The date last disclosure made is the date on which the last disclosure was given to the
licensed market operator and listed issuer for the same substantial holding.
Substantial product holder(s) giving disclosure
You may give 1 disclosure for 2 or more substantial product holders if—
• they have a similar or related substantial holding in the same listed issuer; and
• they are disclosing the same type of event disclosure; and
• they are associates under section 12(1) of the Financial Markets Conduct Act 2013
or connected in the ways set out in section 237(a) to (e) of that Act (and this
association or connection is set out in this form under the heading “Additional
information”); and
• it is clear which information relates to which substantial product holder(s) in the
disclosure, and the disclosure is not confusing in any other way as a consequence.
Summary of substantial holding
Under this heading, state the name(s) of the substantial product holder(s) to which the
summary relates. Separate summaries should be given (repeated within this form or
attached to this form) for each substantial product holder for whom the information differs.
For this disclosure, the total number held in class is the total number of quoted voting
products, in the class, in which the named substantial product holder has a relevant
interest at the time of the relevant event for this disclosure.
For the last disclosure, the total number held in class is the total number of quoted
voting products, in the class, in which the named substantial product holder had a relevant
interest on the date of the relevant event for that disclosure (see the date given for the
relevant event in default form 1 or for the relevant event in default form 2, whichever form
was used for the last disclosure).
If the person has a relevant interest in a derivative where the underlying is a quoted voting
product of a listed issuer, the person is treated as having a relevant interest in a number of
those products that is calculated under regulation 132. Accordingly, the total number
held in class (for this disclosure or the last disclosure or both, as the case may be) must
include this number of products.
For this disclosure, the total in class is the total number of quoted voting products in the
class that was most recently published in a document published by the listed issuer and
distributed to holders of that class, or on the licensed market operator’s Internet site (see
section 283 of the Financial Markets Conduct Act 2013), unless you know that number is
not correct.
For the last disclosure, the total in class is the total stated in the last disclosure, unless
you know that number was not correct.

100080615/3821103.1
The total percentage held in class is the total number held in class (for the relevant
disclosure) divided by the total in class (for the relevant disclosure) multiplied by 100
(rounded to 3 decimal places).
Details of transactions and events giving rise to relevant event
Disclosure is required for the transactions or events as a result of which (together or
alone)—
• there was a movement of 1% or more in the substantial holding; or
• there was a change in nature of any relevant interest in the substantial holding.
For each of those transactions or events, or for on-market trades that may be aggregated
under these instructions, insert the following details as a narrative or list, clearly indicating
which relevant interest or interests were affected and (if disclosure is given for more than
1 substantial product holder) who was the substantial product holder:
• the date of the transaction or event (or the date of the beginning and end of the
period of aggregated on-market trades):
• the nature of the transaction or event. This is the means by which the relevant
interest was acquired, disposed of, or changed in nature (for example, “exercise of
options”, “entry into pre-bid agreement”):
• the name of any other party or parties to the transaction or event (if known and if
not an on-market trade):
• the consideration, expressed in New Zealand dollars, paid or received for the
acquisition, disposal, or change in nature of the relevant interest (or the total
consideration paid or received for aggregated on-market trades). If the
consideration was not in cash, and cannot readily be converted into a cash value,
describe that consideration:
• the number of financial products to which the transaction or event related (or the
total number of financial products to which the aggregated on-market trades
related).
On-market trades may be aggregated for the purposes of this disclosure (but acquisitions
and dispositions must be separately aggregated).
An on-market trade is an acquisition or a disposition of a quoted voting product that is
traded on, or reported through, the trading system operated by the licensed market
operator or a financial products market in a jurisdiction set out in Schedule 15.
Details after relevant event
Under this heading, state the name(s) of the substantial product holder(s) to which the
details relate. Separate details should be given (repeated within this form or attached to
this form) for each substantial product holder for whom the information differs.
The disclosure for nature of relevant interest requires you to describe, as at the date of
the relevant event, the nature of each relevant interest in the substantial holding, and to—

100080615/3821103.1
• state that the relevant interest is “qualified” or “conditional” if there is any
qualification on the substantial product holder’s relevant interest power to exercise,
or control the exercise of, a right to vote, acquire, or dispose of any of the financial
products in the substantial holding; and
• include the details of any trust, arrangement, agreement, or understanding under
which, or by virtue of which, the relevant interest or that qualification arises
(relevant agreement); and
• if there is a relevant agreement for a relevant interest or qualification, attach to the
disclosure the relevant agreement (if in writing) or (if the relevant agreement is not
in writing) a document setting out its material terms (a relevant agreement
document) unless—
• the relevant agreement document has been attached to a previous disclosure
and you state this fact and give the date of the previous event disclosure; or
• the exemption for ownership relevant interests under regulation 141 applies;
or
• the investment management contract exemption under regulation 142
applies; or
• the Financial Markets Authority has granted an exemption from
regulation 139.
If you have more than 1 relevant interest in the substantial holding, you must provide this
information for each type of relevant interest (by separately repeating it within this form,
or attaching it to this form, for each relevant interest for which the information differs) and
clearly indicate to which relevant interest the information relates.
The number held in class is the number of quoted voting products, in the class, in which
the named substantial product holder has the described relevant interest.
If the person has a relevant interest in a derivative where the underlying is a quoted voting
product of a listed issuer, the person is treated as having a relevant interest in a number of
those products that is calculated under regulation 132 (and, accordingly, the number held
in class must include this number of products).
The percentage held in class is the number held in class divided by the total in class
multiplied by 100 (rounded to 3 decimal places).
The current registered holder is the person who is the current registered holder of the
financial products to which the relevant interest relates. If this person is not known, state
“unknown”. If there is no change since the last disclosure, state “no change”. If there are
different registered holders for different parcels of financial products, clearly indicate which
registered holder relates to which financial products.
The registered holder once transfers are registered is the person who will be the
registered holder once all transfers (if any) disclosed in the form are registered. If this
person is not known, state “unknown”. If there is no change since the last disclosure,

100080615/3821103.1
state “no change”. If there are different registered holders for different parcels of financial
products, clearly indicate which registered holder relates to which financial products.
If the substantial product holder has a relevant interest in a derivative where the
underlying is a quoted voting product of a listed issuer, the details of derivative requires
the following details to be given:
• the notional value of the derivative (if any) (which is the face value or the notional
amount in respect of the derivative as at the date on which the relevant agreement
is entered into) or the notional number of underlying financial products (if any):
• a statement as to whether the derivative is cash-settled or physically settled:
• the maturity date of the derivative (if any):
• the expiry date of the derivative (if any):
• the prices specified in the terms of the derivative (if any) (eg, the strike price of an
option or the price at which a contract for difference was acquired):
• any other details needed to understand how the amount of the consideration
payable under the derivative or the value of the derivative is affected by the value of
the underlying quoted voting products.
Additional information
The disclosure relating to the nature of connection between substantial product
holders is the justification for giving the disclosure for more than 1 holder (if 1 disclosure
is made for 2 or more holders).
Certification
Under section 512 of the Financial Markets Conduct Act 2013, it is an offence if a person
makes, or authorises the making of, a materially false or misleading statement in this form
knowing it to be false or misleading.

ANNEXURE A
Trade Date
TickerSecurityQuantity
AmountCurr
01-Nov-2024RYMRYMAN HEALTHCARE LTD NPV109,980
$ 548,882.69
NZD
04-Nov-2024RYMRYMAN HEALTHCARE LTD NPV657,110
$ 3,285,352.87
NZD
05-Nov-2024RYMRYMAN HEALTHCARE LTD NPV53,006
$ 261,308.98
NZD
06-Nov-2024RYMRYMAN HEALTHCARE LTD NPV85,834
$ 421,015.77
NZD
07-Nov-2024RYMRYMAN HEALTHCARE LTD NPV561,160
$ 2,769,296.54
NZD
08-Nov-2024RYMRYMAN HEALTHCARE LTD NPV550,838
$ 2,719,725.90
NZD
11-Nov-2024RYMRYMAN HEALTHCARE LTD NPV349,162
$ 1,705,411.96
NZD
12-Nov-2024RYMRYMAN HEALTHCARE LTD NPV525,000
$ 2,558,062.50
NZD
13-Nov-2024RYMRYMAN HEALTHCARE LTD NPV475,000
$ 2,287,813.75
NZD
14-Nov-2024RYMRYMAN HEALTHCARE LTD NPV187,302
$ 901,546.96
NZD
15-Nov-2024RYMRYMAN HEALTHCARE LTD NPV120,000
$ 576,696.00
NZD
18-Nov-2024RYMRYMAN HEALTHCARE LTD NPV265,693
$ 1,272,669.47
NZD
19-Nov-2024RYMRYMAN HEALTHCARE LTD NPV383,984
$ 1,844,447.94
NZD
20-Nov-2024RYMRYMAN HEALTHCARE LTD NPV88,577
$ 428,531.10
NZD
21-Nov-2024RYMRYMAN HEALTHCARE LTD NPV261,746
$ 1,301,610.51
NZD
25-Nov-2024RYMRYMAN HEALTHCARE LTD NPV-16,668
$ 84,506.76
NZD
26-Nov-2024RYMRYMAN HEALTHCARE LTD NPV76,398
$ 382,753.98
NZD
27-Nov-2024RYMRYMAN HEALTHCARE LTD NPV225,000
$ 1,129,500.00
NZD
28-Nov-2024RYMRYMAN HEALTHCARE LTD NPV1,722,641
$ 8,138,395.92
NZD
29-Nov-2024RYMRYMAN HEALTHCARE LTD NPV119,722
$ 555,613.84
NZD
02-Dec-2024RYMRYMAN HEALTHCARE LTD NPV678,168
$ 3,133,339.61
NZD
03-Dec-2024RYMRYMAN HEALTHCARE LTD NPV2,412,038
$ 11,133,243.80
NZD

ANNEXURE B
Holder of Relevant InterestRegistered Holder of Securities
Persons entitled to be registered as holderNature of Relevant InterestNumber of Securities Persons Votes
Cooper Investors Pty LtdNational Nominees LtdNational Nominees LtdInvestment Manager2,079,254 2,079,254
Cooper Investors Pty LtdJP Morgan Nominees Australia Pty Ltd
JP Morgan Nominees Australia Pty LtdInvestment Manager4,151,199 4,151,199
Cooper Investors Pty LtdState Street Australia LimitedState Street Australia LimitedInvestment Manager
20,295,269 20,295,269
Cooper Investors Pty LtdNorthern TrustNorthern TrustInvestment Manager280,636
280,636
Cooper Investors Pty LtdCiti Group Citi Group Investment Manager15,760,878 15,760,878
Cooper Investors Pty LtdBNP ParibasBNP ParibasInvestment Manager2,220,526 2,220,526
Total holdings44,787,762
44,787,762
Total Shares Outstanding687,641,738
Percentage holding6.5132%